Treatment safety of non-vitamin K oral anticoagulants in patients with atrial fibrillation

被引:0
作者
Hohnloser, S. H. [1 ]
机构
[1] Goethe Univ Frankfurt, Abt Klin Elektrophysiol, Kardiol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany
关键词
Anticoagulants; Non-vitamin K dependent oral anticoagulants; Risk of bleeding; Specific antidotes; Idarucizumab; IDARUCIZUMAB; DABIGATRAN; TOLERABILITY; ANTIDOTE; REVERSAL; WARFARIN; PHARMACOKINETICS; VOLUNTEERS; APIXABAN; EDOXABAN;
D O I
10.1007/s00059-015-4383-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Non-vitamin K oral anticoagulants (NOAC) have now become established for stroke prevention in atrial fibrillation. The efficacy is at least as good if not better than that of vitamin K antagonists (VKA). The risk for major bleeding is less for NOAC than for VKA, with a particular superiority concerning the avoidance of intracerebral hemorrhage. The outcome after major bleeding is more favorable in patients receiving NOAC compared to those treated with VKA. Specific reversal agents for NOAC are currently being tested which neutralize the effects of NOAC within minutes and the clinical introduction of the first one for the thrombin inhibitor dabigatran is imminent. Such specific antidotes will further improve the safety profile of NAOC.
引用
收藏
页码:37 / 45
页数:9
相关论文
共 22 条
[1]  
[Anonymous], CIRCULATION
[2]   Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry [J].
Beyer-Westendorf, Jan ;
Foerster, Kati ;
Pannach, Sven ;
Ebertz, Franziska ;
Gelbricht, Vera ;
Thieme, Christoph ;
Michalski, Franziska ;
Koehler, Christina ;
Werth, Sebastian ;
Sahin, Kurtulus ;
Tittl, Luise ;
Haensel, Ulrike ;
Weiss, Norbert .
BLOOD, 2014, 124 (06) :955-962
[3]   Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis [J].
Caldeira, Daniel ;
Rodrigues, Filipe B. ;
Barra, Marcio ;
Santos, Ana Teresa ;
de Abreu, Daisy ;
Goncalves, Nilza ;
Pinto, Fausto J. ;
Ferreira, Joaquim J. ;
Costa, Joao .
HEART, 2015, 101 (15) :1204-1211
[4]   2012 focused update of the ESC Guidelines for the management of atrial fibrillation [J].
Camm, A. John ;
Lip, Gregory Y. H. ;
De Caterina, Raffaele ;
Savelieva, Irene ;
Atar, Dan ;
Hohnloser, Stefan H. ;
Hindricks, Gerhard ;
Kirchhof, Paulus ;
Bax, Jeroen J. ;
Baumgartner, Helmut ;
Ceconi, Claudio ;
Dean, Veronica ;
Deaton, Christi ;
Fagard, Robert ;
Funck-Brentano, Christian ;
Hasdai, David ;
Hoes, Arno ;
Knuuti, Juhani ;
Kolh, Philippe ;
McDonagh, Theresa ;
Moulin, Cyril ;
Popescu, Bogdan A. ;
Reiner, Zeljko ;
Sechtem, Udo ;
Sirnes, Per Anton ;
Tendera, Michal ;
Torbicki, Adam ;
Vahanian, Alec ;
Windecker, Stephan ;
Vardas, Panos ;
Al-Attar, Nawwar ;
Alfieri, Ottavio ;
Angelini, Annalisa ;
Blomstrom-Lundqvist, Carina ;
Colonna, Paolo ;
De Sutter, Johan ;
Ernst, Sabine ;
Goette, Andreas ;
Gorenek, Bulent ;
Hatala, Robert ;
Heidbuchel, Hein ;
Heldal, Magnus ;
Kristensen, Steen Dalby ;
Le Heuzey, Jean-Yves ;
Mavrakis, Hercules ;
Mont, Lluis ;
Filardi, Pasquale Perrone ;
Ponikowski, Piotr ;
Prendergast, Bernard ;
Rutten, Frans H. .
EUROPEAN HEART JOURNAL, 2012, 33 (21) :2719-2747
[5]   Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].
Connolly, Stuart J. ;
Ezekowitz, Michael D. ;
Yusuf, Salim ;
Eikelboom, John ;
Oldgren, Jonas ;
Parekh, Amit ;
Pogue, Janice ;
Reilly, Paul A. ;
Themeles, Ellison ;
Varrone, Jeanne ;
Wang, Susan ;
Alings, Marco ;
Xavier, Denis ;
Zhu, Jun ;
Diaz, Rafael ;
Lewis, Basil S. ;
Darius, Harald ;
Diener, Hans-Christoph ;
Joyner, Campbell D. ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151
[6]   Edoxaban versus Warfarin in Patients with Atrial Fibrillation [J].
Giugliano, Robert P. ;
Ruff, Christian T. ;
Braunwald, Eugene ;
Murphy, Sabina A. ;
Wiviott, Stephen D. ;
Halperin, Jonathan L. ;
Waldo, Albert L. ;
Ezekowitz, Michael D. ;
Weitz, Jeffrey I. ;
Spinar, Jindrich ;
Ruzyllo, Witold ;
Ruda, Mikhail ;
Koretsune, Yukihiro ;
Betcher, Joshua ;
Shi, Minggao ;
Grip, Laura T. ;
Patel, Shirali P. ;
Patel, Indravadan ;
Hanyok, James J. ;
Mercuri, Michele ;
Vogelmann, O. ;
Gonzalez, C. ;
Ahuad Guerrero, R. ;
Rodriguez, M. ;
Albisu, J. ;
Rosales, E. ;
Allall, O. ;
Reguero, M. ;
Alvarez, C. ;
Garcia, M. ;
Ameriso, S. ;
Ameriso, P. ;
Amuchastegui, M. ;
Caceres, M. ;
Beloscar, J. ;
Petrucci, J. ;
Berli, M. ;
Budassi, N. ;
Valle, M. ;
Bustamante Labarta, G. ;
Saravia, M. ;
Caccavo, A. ;
Fracaro, V. ;
Cartasegna, L. ;
Novas, V. ;
Caruso, O. ;
Saa Zarandon, R. ;
Colombo, H. ;
Morandini, M. ;
Cuello, J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (22) :2093-2104
[7]   Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial [J].
Glund, Stephan ;
Stangier, Joachim ;
Schmohl, Michael ;
Gansser, Dietmar ;
Norris, Stephen ;
van Ryn, Joanne ;
Lang, Benjamin ;
Ramael, Steven ;
Moschetti, Viktoria ;
Gruenenfelder, Fredrik ;
Reilly, Paul ;
Kreuzer, Joerg .
LANCET, 2015, 386 (9994) :680-690
[8]   A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran [J].
Glund, Stephan ;
Moschetti, Viktoria ;
Norris, Stephen ;
Stangier, Joachim ;
Schmohl, Michael ;
van Ryn, Joanne ;
Lang, Benjamin ;
Ramael, Steven ;
Reilly, Paul .
THROMBOSIS AND HAEMOSTASIS, 2015, 113 (05) :943-951
[9]  
Gomes T, 2013, CMAJ, V186, pE127
[10]   Apixaban versus Warfarin in Patients with Atrial Fibrillation [J].
Granger, Christopher B. ;
Alexander, John H. ;
McMurray, John J. V. ;
Lopes, Renato D. ;
Hylek, Elaine M. ;
Hanna, Michael ;
Al-Khalidi, Hussein R. ;
Ansell, Jack ;
Atar, Dan ;
Avezum, Alvaro ;
Cecilia Bahit, M. ;
Diaz, Rafael ;
Easton, J. Donald ;
Ezekowitz, Justin A. ;
Flaker, Greg ;
Garcia, David ;
Geraldes, Margarida ;
Gersh, Bernard J. ;
Golitsyn, Sergey ;
Goto, Shinya ;
Hermosillo, Antonio G. ;
Hohnloser, Stefan H. ;
Horowitz, John ;
Mohan, Puneet ;
Jansky, Petr ;
Lewis, Basil S. ;
Luis Lopez-Sendon, Jose ;
Pais, Prem ;
Parkhomenko, Alexander ;
Verheugt, Freek W. A. ;
Zhu, Jun ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (11) :981-992